ArticlePulmonary therapy2025

Correction: A Phase 2a, Randomized, Placebo-Controlled Human Challenge Trial to Evaluate the Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated with Respiratory Syncytial Virus.

Mickie H Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.